Dr. Francis Collins Will Continue Serving as NIH Director and FNIH Ex-Officio Board Member
North Bethesda, MD, January 15, 2021 — President-elect Joe Biden has asked Francis Collins, M.D., Ph.D., ex-officio member of the Foundation for the National Institutes of Health (FNIH) Board of Directors, to remain as Director of the National Institutes of Health (NIH), according to his transition team. The FNIH is delighted that Dr. Collins will continue to serve in this role, which he has held since 2009 when he was appointed by former President Barack Obama.
“This is welcomed news for the entire biomedical research enterprise,” said Maria C. Freire, Ph.D., President and Executive Director of the FNIH. “We look forward to continued progress on important research initiatives with our partner, the NIH, including our work through the Accelerating COVID-19 Therapeutic Interventions and Vaccines program (ACTIV).”
Dr. Collins’ leadership has extended across many groundbreaking FNIH programs, including the Accelerating Medicines Partnership as well as the Partnership for Accelerating Cancer Therapies.
About the Foundation for the National Institutes of Health The Foundation for the National Institutes of Health creates and manages alliances with public and private institutions in support of the mission of the NIH, the world’s premier medical research agency. The Foundation, also known as the FNIH, works with its partners to accelerate biomedical research and strategies against diseases and health concerns in the United States and across the globe. The FNIH organizes and administers research projects; supports education and training of new researchers; organizes educational events and symposia; and administers a series of funds supporting a wide range of health issues. Established by Congress in 1990, the FNIH is a not-for-profit 501(c)(3) charitable organization. For additional information about the FNIH, please visit https://fnih.org.